Silence Therapeutics
Financial ratios & Valuation

Forward Multiples (2025 – 2028)

2025202620272028
Price/Earnings ratio
-13.85-10.23-10.18-21.22
Price/Sales ratio
5.166.802.811.00
Earnings per Share (EPS)
$-0.39$-0.53$-0.54$-0.26

Historical Multiples (2014 – 2023)

2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 TTM Median
Valuation Ratios
Price/Earnings ratio
-18.96-42.49-43.54-207.97-19.45-18.80-13.48-13.27-10.02-11.70-4.08-19.45
Price/Sales ratio
14.02KN/A477.3021.03KN/A1.50K80.1042.1523.1919.969.141.50K
Price/Book Value ratio
7.574.676.786.4210.2117.6148.4461.3818.3829.714.3217.61
Price/Cash Flow ratio
-22.23-34.21-36.51-35.05-21.37213.21-40.7276.89-8.92-12.87-4.31-21.37
Price/Free Cash Flow ratio
-21.47-31.01-34.66-34.43-21.13214.33-38.8795.64-8.84-12.85-4.22-21.13
Price/Earnings Growth ratio
-2.310.80-2.692.57-0.0114.85-0.25-1.121.901.630.34-0.01
Dividend Yield
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Profitability Indicator Ratios
Gross Profit Margin
-59126.66%N/A-1031.29%-49543.75%N/A100%31.33%39.94%37.83%59.33%43.88%100%
Operating Profit Margin
-80846.66%N/A-1546.23%-89943.75%N/A-9317.21%-654.26%-369.02%-277.65%-195.48%-302.75%-302.75%
Pretax Profit Margin
-79866.66%N/A-1345.71%-23593.75%N/A-9372.95%-657.80%-369.35%-270.65%-198.26%-269.62%-269.62%
Net Profit Margin
-73920%N/A-1096.10%-10112.5%N/A-8025.40%-594.03%-317.43%-231.35%-170.51%-223.90%-223.90%
Effective Tax Rate
7.44%29.52%18.54%57.13%10.30%14.37%9.69%14.05%14.52%13.99%16.95%10.30%
Return on Assets
-37.24%-10.79%-15.12%-2.94%-47.34%-42.49%-37.85%-40.96%-37.66%-46.11%-29.15%-47.34%
Return On Equity
-39.94%-10.99%-15.57%-3.09%-52.52%-93.65%-359.27%-462.23%-183.44%-253.76%-345.14%-93.65%
Return on Capital Employed
-43.68%-16.16%-21.97%-27.49%-58.68%-62.41%-59.35%-56.54%-56.79%-65.22%-49.84%-58.68%
Liquidity Ratios
Current Ratio
N/AN/AN/AN/AN/AN/A2.98N/AN/AN/A4.37N/A
Quick Ratio
11.2349.3627.9518.078.343.882.925.695.154.553.973.88
Cash ratio
8.3746.4224.2316.085.611.401.074.842.493.043.471.40
Days of Sales Outstanding
N/AN/A383.96N/AN/A5.26K1.95K249.51361.683.27295.975.26K
Days of Inventory outstanding
-15.40-84.09-125.45-114.09-91.63N/A144.750.00-551.08N/AN/A-91.63
Operating Cycle
-15.40N/A258.50-114.09N/AN/A2.09K249.51-189.403.2772.98N/A
Days of Payables Outstanding
22.1810.6222.1221.2342.96N/A221.69198.99106.8893.00596.4542.96
Cash Conversion Cycle
-37.59N/A236.38-135.32N/AN/A1.87K50.51-296.28-89.72-300.47N/A
Debt Ratios
Debt Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/A0.72N/A
Debt Equity Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/A2.63N/A
Long-term Debt to Capitalization
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Total Debt to Capitalization
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Interest Coverage Ratio
N/AN/AN/AN/AN/AN/A-1.77KN/AN/AN/A-50.14N/A
Cash Flow to Debt Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Company Equity Multiplier
1.071.011.021.051.102.209.4911.284.875.503.631.10
Cash Flow Ratios
Operating Cash Flow / Sales Ratio
-630.53N/A-13.07-599.93N/A7.07-1.960.54-2.59-1.55-2.127.07
Free Cash Flow / Operating Cash Flow Ratio
1.031.101.051.011.010.991.040.801.001.001.021.01
Cash Flow Coverage Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Short Term Coverage Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/A-68.64N/A
Dividend Payout Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A